vs
AVITA Medical, Inc.（RCEL）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
AVITA Medical, Inc.的季度营收约是RIVERVIEW BANCORP INC的1.3倍（$17.6M vs $14.0M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -66.0%，领先75.8%），RIVERVIEW BANCORP INC同比增速更快（10.4% vs -4.3%），RIVERVIEW BANCORP INC自由现金流更多（$-736.0K vs $-6.1M），过去两年AVITA Medical, Inc.的营收复合增速更高（26.0% vs 24.6%）
AVITA Medical是一家聚焦再生医学领域的产业化企业，专注于多款再生医疗产品的研发与市场推广。公司首款上市产品ReCell喷雾皮肤产品用于烧伤治疗，最新推出两款产品：面向医美整形领域、用于皮肤损伤修复的ReNovaCell，以及针对慢性伤口治疗的ReGenerCell。目前公司的再生产品管线已在欧洲、中东地区实现商业化销售。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
RCEL vs RVSB — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $17.6M | $14.0M |
| 净利润 | $-11.6M | $1.4M |
| 毛利率 | 81.2% | — |
| 营业利润率 | -59.1% | 12.4% |
| 净利率 | -66.0% | 9.8% |
| 营收同比 | -4.3% | 10.4% |
| 净利润同比 | -0.3% | 11.8% |
| 每股收益（稀释后） | $-0.37 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $17.6M | $14.0M | ||
| Q3 25 | $17.1M | $13.6M | ||
| Q2 25 | $18.4M | $13.3M | ||
| Q1 25 | $18.5M | $12.9M | ||
| Q4 24 | $18.4M | $12.7M | ||
| Q3 24 | $19.5M | $12.8M | ||
| Q2 24 | $15.2M | $12.2M | ||
| Q1 24 | $11.1M | $9.0M |
| Q4 25 | $-11.6M | $1.4M | ||
| Q3 25 | $-13.2M | $1.1M | ||
| Q2 25 | $-9.9M | $1.2M | ||
| Q1 25 | $-13.9M | $1.1M | ||
| Q4 24 | $-11.6M | $1.2M | ||
| Q3 24 | $-16.2M | $1.6M | ||
| Q2 24 | $-15.4M | $966.0K | ||
| Q1 24 | $-18.7M | $-3.0M |
| Q4 25 | 81.2% | — | ||
| Q3 25 | 81.3% | — | ||
| Q2 25 | 81.2% | — | ||
| Q1 25 | 84.7% | — | ||
| Q4 24 | 87.6% | — | ||
| Q3 24 | 83.7% | — | ||
| Q2 24 | 86.1% | — | ||
| Q1 24 | 86.4% | — |
| Q4 25 | -59.1% | 12.4% | ||
| Q3 25 | -53.6% | 10.2% | ||
| Q2 25 | -60.5% | 11.7% | ||
| Q1 25 | -63.9% | 11.3% | ||
| Q4 24 | -54.1% | 12.4% | ||
| Q3 24 | -70.6% | 15.5% | ||
| Q2 24 | -102.8% | 10.0% | ||
| Q1 24 | -155.0% | -47.5% |
| Q4 25 | -66.0% | 9.8% | ||
| Q3 25 | -77.3% | 8.1% | ||
| Q2 25 | -53.9% | 9.2% | ||
| Q1 25 | -74.9% | 8.9% | ||
| Q4 24 | -63.0% | 9.7% | ||
| Q3 24 | -82.9% | 12.2% | ||
| Q2 24 | -101.3% | 7.9% | ||
| Q1 24 | -168.0% | -34.7% |
| Q4 25 | $-0.37 | $0.07 | ||
| Q3 25 | $-0.46 | $0.05 | ||
| Q2 25 | $-0.38 | $0.06 | ||
| Q1 25 | $-0.53 | $0.05 | ||
| Q4 24 | $-0.44 | $0.06 | ||
| Q3 24 | $-0.62 | $0.07 | ||
| Q2 24 | $-0.60 | $0.05 | ||
| Q1 24 | $-0.73 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.2M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-16.6M | $164.2M |
| 总资产 | $56.4M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $18.2M | $28.6M | ||
| Q3 25 | $23.3M | $32.8M | ||
| Q2 25 | $15.7M | $34.2M | ||
| Q1 25 | $25.8M | $29.4M | ||
| Q4 24 | $35.9M | $25.3M | ||
| Q3 24 | $44.4M | $31.0M | ||
| Q2 24 | $54.1M | $27.8M | ||
| Q1 24 | $68.2M | $23.6M |
| Q4 25 | $-16.6M | $164.2M | ||
| Q3 25 | $-6.7M | $163.5M | ||
| Q2 25 | $-12.9M | $162.0M | ||
| Q1 25 | $-4.6M | $160.0M | ||
| Q4 24 | $4.5M | $158.3M | ||
| Q3 24 | $12.2M | $160.8M | ||
| Q2 24 | $23.9M | $155.9M | ||
| Q1 24 | $32.6M | $155.6M |
| Q4 25 | $56.4M | $1.5B | ||
| Q3 25 | $63.7M | $1.5B | ||
| Q2 25 | $58.1M | $1.5B | ||
| Q1 25 | $69.6M | $1.5B | ||
| Q4 24 | $79.7M | $1.5B | ||
| Q3 24 | $81.1M | $1.5B | ||
| Q2 24 | $87.8M | $1.5B | ||
| Q1 24 | $97.4M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.4M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $-6.1M | $-736.0K |
| 自由现金流率自由现金流/营收 | -34.7% | -5.2% |
| 资本支出强度资本支出/营收 | 3.8% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | $-33.5M | $20.4M |
8季度趋势，按日历期对齐
| Q4 25 | $-5.4M | $-506.0K | ||
| Q3 25 | $-5.2M | $16.8M | ||
| Q2 25 | $-10.2M | $-697.0K | ||
| Q1 25 | $-10.3M | $8.3M | ||
| Q4 24 | $-8.1M | $2.2M | ||
| Q3 24 | $-7.2M | $764.0K | ||
| Q2 24 | $-12.8M | $5.4M | ||
| Q1 24 | $-20.9M | $12.8M |
| Q4 25 | $-6.1M | $-736.0K | ||
| Q3 25 | $-6.2M | $16.4M | ||
| Q2 25 | $-10.8M | $-773.0K | ||
| Q1 25 | $-10.5M | $5.6M | ||
| Q4 24 | $-9.7M | $1.9M | ||
| Q3 24 | $-11.0M | $-1.4M | ||
| Q2 24 | $-15.4M | $5.3M | ||
| Q1 24 | $-22.0M | $7.1M |
| Q4 25 | -34.7% | -5.2% | ||
| Q3 25 | -36.1% | 120.1% | ||
| Q2 25 | -58.4% | -5.8% | ||
| Q1 25 | -56.9% | 43.1% | ||
| Q4 24 | -52.7% | 15.0% | ||
| Q3 24 | -56.1% | -11.3% | ||
| Q2 24 | -101.6% | 43.7% | ||
| Q1 24 | -198.2% | 79.0% |
| Q4 25 | 3.8% | 1.6% | ||
| Q3 25 | 5.5% | 2.9% | ||
| Q2 25 | 2.8% | 0.6% | ||
| Q1 25 | 1.2% | 21.0% | ||
| Q4 24 | 8.8% | 2.4% | ||
| Q3 24 | 19.2% | 17.3% | ||
| Q2 24 | 17.5% | 0.9% | ||
| Q1 24 | 10.3% | 62.0% |
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
